Skip to main content
. 2022 Feb 17;23(4):2235. doi: 10.3390/ijms23042235

Figure 2.

Figure 2

Figure 2

Immunomorphological characteristics of pathological cellular infiltration of the stroma of the lung’s respiratory parts among patients with new coronavirus infection caused by SARSCov2 (COVID-19). Acute (exudative) phase of diffuse alveolar damage (left). (A) staining with hematoxylin and eosin, ×400; (C) expression of CD3 (clone SP7, Diagnostic BioSystems, Pleasanton, CA, USA), ×400; (E) expression of CD4 (clone SP35, Cell Marque, Rocklin, CA, USA), ×400; (G) expression of CD8 (clone 144B, Diagnostic BioSystems, USA), ×400; (I) expression of CD68 (clone Kp-1, Cell Marque, USA. Late (proliferative) phase of diffuse alveolar damage (right). (B) staining with hematoxylin and eosin, ×400; (D) expression of CD3 (clone SP7, Diagnostic BioSystems, USA), ×400; (F) CD4 expression (clone SP35, Cell Marque, USA), ×400; (H) CD8 expression (clone 144B, Diagnostic BioSystems, USA), ×400; (J) CD68 expression (clone Kp-1, Cell Marque, USA), ×400.